A Comprehensive Review on Stem Cell Therapy and CRISPR/Cas Technology in the Treatment of Thalassemia
Thalassemia is a widespread hereditary blood disorder, characterized by defective or impaired production of the ???? or ????-globin chains that make up hemoglobin. This imbalance leads to ineffective erythropoiesis, anemia and additional associated symptoms. Current therapeutic strategies largely rely on hematopoietic...